12 Hrs
Source:
الاتحاد
AI Aids Rare Cancer Patients
Researchers at the MD Anderson Cancer Center at the University of Texas have demonstrated that analyzing tumor biopsies with artificial intelligence can predict patients' responsiveness to immunotherapy in rare cancers. The study showed that combining immune cell markers with tumor size improves the accuracy of predictions, reducing the risk of disease progression by 64% and increasing the average survival time to 42 months compared to 10 months. However, these findings are currently being validated with larger groups before they can be applied clinically.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)